Company Filing History:
Years Active: 2018
Title: Shoujun Chen: Innovator in Pharmaceutical Compounds
Introduction
Shoujun Chen is a notable inventor based in Ann Arbor, MI (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target specific medical disorders. His work is characterized by a focus on innovative solutions for complex health issues.
Latest Patents
Shoujun Chen holds a patent for "Indazolyl thiadiazolamines and related compounds for inhibition of Rho-associated protein kinase and the treatment of disease." This invention provides indazolyl thiadiazolamines and related compounds, pharmaceutical compositions, methods of inhibiting Rho-associated protein kinase, and methods of treating inflammatory disorders, immune disorders, fibrotic disorders, and other medical disorders using such compounds. An exemplary indazolyl thiadiazolamine compound is an N-(5-[5-[(1H-indazol-5-yl)amino]-1,3,4-thiadiazol-2-yl]pyridin-3-yl)acetamide compound. He has 1 patent to his name.
Career Highlights
Shoujun Chen is currently associated with Lycera Corporation, where he continues to advance his research and development efforts. His work at Lycera Corporation emphasizes the importance of innovative pharmaceutical solutions that can address unmet medical needs.
Collaborations
Some of his notable coworkers include Thomas Daniel Aicher and Fernando Padilla. Their collaborative efforts contribute to the innovative environment at Lycera Corporation.
Conclusion
Shoujun Chen is a prominent figure in the pharmaceutical industry, recognized for his innovative contributions to medical science. His work on indazolyl thiadiazolamines showcases his commitment to developing effective treatments for various disorders.